Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Tackling the diversity of triple negative early breast cancer (TNBC)

Should we incorporate immunotherapy in early breast cancer?

Date

29 Sep 2019

Session

Tackling the diversity of triple negative early breast cancer (TNBC)

Topics

Tumour Site

Breast Cancer

Presenters

Rebecca Dent

Authors

R. Dent

Author affiliations

  • NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Rebecca Dent

Session: Tackling the diversity of triple negative early breast cancer (TNBC)

Resources:

Slides

Webcast

Conclusions and perspectives

Presenter: Veronique Dieras

Session: Tackling the diversity of triple negative early breast cancer (TNBC)

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.